“Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension”, Ukr. j. ophthalmol. , no. 2, pp. 37–41, Aug. 2025, doi: 10.31288/oftalmolzh202223741.